Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Musa paradisiaca stem juice is a natural extract derived from the pseudostem of the plantain plant. It is utilized in traditional medicine and has been investigated in preclinical research for its potential neuroprotective and antiepileptic properties. Studies in rat models of epilepsy have demonstrated that oral administration of the juice can mitigate neuronal damage, preserve Nissl substance staining intensity, and reduce reactive astrogliosis (the dense population of astrocytes) following seizures induced by agents like pentylenetetrazole. While its exact molecular mechanism of action is not fully defined, its therapeutic effects are associated with the protection of neuronal architecture and the modulation of glial cell responses in the brain.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on musa paradisiaca stem juice.